Funding for this research was provided by:
Stiftung Synapsis - Alzheimer Forschung Schweiz AFS (2017-PI01)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF 320030_141179)
Received: 30 November 2020
Accepted: 23 March 2021
First Online: 1 April 2021
: The local ethics committee of Vaud, Switzerland, approved this study (No. 171/2013), and all participants or their legal representatives provided written informed consent.
: Not applicable
: JP received consultation honoraria from Nestle Institute of Health Sciences, Innovation Campus, EPFL, Lausanne, Switzerland, Ono Pharma, and from Fujirebio Europe. The other authors declare no potential conflicts of interest.